Alberto Pérez-Mediavilla

Dr. Alberto Pérez-Mediavilla

Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarre, Spain
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2009 in Neuropsychopharmacology
Verified
Journal Article
Closed access
ARAna Ricobaraza
Ana Ricobaraza
MCMar Cuadrado-Tejedor
Mar Cuadrado-Tejedor
APAlberto Pérez-Mediavilla
Alberto Pérez-Mediavilla
DFDiana Frechilla
Diana Frechilla
JRJoaquin Del Río
Joaquin Del Río
AGAna Garcia-Osta
Ana Garcia-Osta

24 March 2010 in Neuropsychopharmacology
Verified
Journal Article
Closed access
LELuis Escribano
Luis Escribano
ASAna-María Simón
Ana-María Simón
EGEsther Gimeno
Esther Gimeno
MCMar Cuadrado-Tejedor
Mar Cuadrado-Tejedor
RMRakel López de Maturana
Rakel López de Maturana
DFDiana Frechilla
Diana Frechilla

26 February 2011 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MCMar Cuadrado-Tejedor
Mar Cuadrado-Tejedor
MVMarcos Vilariño
Marcos Vilariño
FCFelipe Cabodevilla
Felipe Cabodevilla
JRJoaquín Del Río
Joaquín Del Río
DFDiana Frechilla
Diana Frechilla
APAlberto Pérez-Mediavilla
Alberto Pérez-Mediavilla
The mitochondrial voltage-dependent anion channel 1 (VDAC1) is involved in the release of apoptotic proteins with possible relevance in Alzheimer's disease (AD) neuropathology. Through proteomic analysis followed by Western blotting and immunohistoch

1 February 2009 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LELuis Escribano
Luis Escribano
ASAna-María Simón
Ana-María Simón
APAlberto Pérez-Mediavilla
Alberto Pérez-Mediavilla
PSPablo Salazar-Colocho
Pablo Salazar-Colocho
JRJoaquín Del Río
Joaquín Del Río
DFDiana Frechilla
Diana Frechilla

26 July 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
SRSara E. Rubio
Sara E. Rubio
GVGerman Vega-Flores
German Vega-Flores
AMAlbert Martínez
Albert Martínez
CBCarles Bosch
Carles Bosch
APAlberto Pérez-Mediavilla
Alberto Pérez-Mediavilla
MPMarta Pascual
Marta Pascual
Patients with Alzheimer's disease (AD) display altered functioning of cortical networks, including altered patterns of synchronous activity and a serious deficit in cholinergic septohippocampal (SH) innervation. However, the mechanisms underlying these alterations and the implication of the GABAergic SH component in AD are largely unknown. In addition, the GABAergic septohippocampal pathway (SHP) is believed to regulate synchronous hippocampal activity by controlling the activity of interneurons. Here we show, using well‐characterized pathway tracing experiments, that innervation of the GABAergic SHP decreases during normal aging. Furthermore, in an AD mouse model (hAPP Sw,Ind ; J20 mice), the GABAergic SHP shows a dramatic and early onset of this decrease in 8‐mo‐old mice. This decline is not caused by neuronal loss, but by the reduced number and complexity of GABAergic SH axon terminals. Finally, we demonstrate that hippocampal θ and γ rhythm power spectra are markedly diminished in 8‐mo‐old behaving mice expressing mutated hAPP. In addition to the well‐known loss of cholinergic input to the hippocampus in AD, these data suggest that the altered patterns of synchronous activity seen in patients with AD could be caused by the loss of GABAergic SH axons, which modulate hippocampal network activities.—Rubio, S. E., Vega‐Flores, G., Martínez, A., Bosch, C., Pérez‐Mediavilla, A., del Río, J., Gruart, A., Delgado‐García, J. M., Soriano, E., Pascual, M. Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease. FASEB J. 26, 4458–4467 (2012). www.fasebj.org

23 July 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
ASAna María Simón
Ana María Simón
RMRakel López De Maturana
Rakel López De Maturana
ARAna Ricobaraza
Ana Ricobaraza
LELuis Escribano
Luis Escribano
LSLucio Schiapparelli
Lucio Schiapparelli
DFDiana Frechilla
Diana Frechilla
Synapse loss occurs early in Alzheimer's disease (AD) and is considered thebest pathological correlate of cognitive decline. Ephrins and Eph receptorsare involved in regulation of excitatory neurotransmission and play a rolein cytoskeleton remodeling